Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis.Published in:Annals of Neurology, 1995, v. 37, n. 1, p. 30, doi. 10.1002/ana.410370108By:Goodkin, Donald E.;Rudick, Richard A.;Medendorp, Sharon Vanderbrug;Daughtry, Michele M.;Schwetz, Kathleen M.;Fischer, Jill;van Dyke, CarolynPublication type:Article